Semiconductor device manufacturing: process – Including control responsive to sensed condition – Optical characteristic sensed
Patent
1997-07-15
1999-03-30
Scheiner, Toni R.
Semiconductor device manufacturing: process
Including control responsive to sensed condition
Optical characteristic sensed
435 6, 436 64, 436813, G01N 33574, C12Q 168
Patent
active
058887512
ABSTRACT:
The invention involves the recognition of a previously identified protein, SCP-1, as a marker for cell transformation. Diagnostic and therapeutic uses of this protein and related molecules are taught. Also disclosed is a method for identifying substances which are immunoreactive and indicative of pathological conditions, using normal cells as source material.
REFERENCES:
Tureci et al., PNAS, vol. 95, No. 9, pp. 5211-5216, Apr. 28, 1998.
Heyting et al., "Synaptonemal Complex Proteins", Genome 31: 81-87 (1989).
Meuwissen et al., "A coiled coil related protein specific for synapsed regions of meiotic prophase chromosome", EMBO J 11 (13:5091-5100 (1992).
Sage et al., cDNA sequence of the murine synaptonemal complex protein 1 (SCP1) Biochimica Biophipica Acta 1263: 258-260 (1995).
Meuwissen et al., "Human Synaptonemal Complex Protein 1 (SCP1) : Isolation and Characterization of the cDNA and Chromosomal Localization of the Gene", Genomics 39: 377-384 (1996).
Pfreundschuh Michael
Sahin Ugur
Tureci Ozlem
Ludwig Institute for Cancer Research
Scheiner Toni R.
LandOfFree
Method for diagnosis and treating cancers, and methods for ident does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for diagnosis and treating cancers, and methods for ident, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for diagnosis and treating cancers, and methods for ident will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1213570